Skip to content

Novel noninvasive brain-computer interfaces: Theory, Technology, and Application Demonstration -- Subtopic 7: Noninvasive BCI for Space missions and Application Validation

Novel noninvasive brain-computer interfaces: Theory, Technology, and Application Demonstration -- Subtopic 7: Noninvasive BCI for Space missions and Application Validation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081738
Enrollment
Unknown
Registered
2024-03-11
Start date
2024-04-02
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotional disorder

Interventions

group1:Cognitive tasks are performed simultaneously during electrical stimulation, in which attentional perception is interfered with transcranial alternating current stimulation (tACS) at alpha frequ
group2:The executive control task was performed simultaneously during the electrical stimulation, and the executive control ability intervention was performed using tACS (stimulation of the prefrontal

Sponsors

Medical Ethics Committee of Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.1 Inclusion criteria for patients with emotional disorders: 1) Aged between 18 and 60 years; 2) Meet the DSM-5 and ICD-10 combined criteria for anxiety and depression: 3) High school education or above; 4) Be able to take measurements and provide informed consent to participate in this study. 1.2 Inclusion criteria for healthy controls: 1) Aged between 18 and 60 years; 2) Good mental state, no self-reported emotional and cognitive impairment; 3) High school education or above; 4) Be able to take measurements and provide informed consent to participate in this study

Exclusion criteria

Exclusion criteria: 1.3 Exclusion criteria: 1) The Hamilton Anxiety/Depression Scale indicates severe anxiety/depression, or suicidal tendencies; 2) Subjects with organic brain disease or other conditions that may result in cognitive impairment or inability to participate in the study to physical disease; 3) In the month prior to this study, any medication that may have affected cognitive function or response rate of the brain was taken substances (excluding medications for mood disorders); 4) Pregnant women, women of childbearing age and breastfeeding women who plan to get pregnant during the trial period; 5) EEG or MRI contraindications are present; 6) Clinicians considered it inappropriate to participate in this study

Design outcomes

Primary

MeasureTime frame
EEG data;

Secondary

MeasureTime frame
Serum cortisol;Immune-related factors (IL-2, IL-6);

Countries

China

Contacts

Public ContactYu Nengwei

Sichuan Provincial People's Hospital

18981838652@163.com+86 189 8183 8652

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026